Telo Genomics Corp. (TELO.V) TSXV

0.05

+0.005(+11.11%)

Updated at January 13 10:37AM

Currency In CAD

Valuation

Market Cap9.65M
Enterprise Value8.86M
P/E Ratio-1.85
PEG Ratio-0.29
Price/Sales Ratio0
Price/Book Ratio-187.96
Enterprise/Revenue0
Enterprise/EBITDA-1.69

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-4.46
Return On Equity-3.22

Income Statement

Revenue0
Revenue/Share0
Gross Profit-14,452
EBITDA-2.69M
Net Income-2.72M
Diluted EPS-0.03

Balance Sheet

Total Cash486,508
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0.93
Book Value Per Share-0

Price History

52-Week Change-52.38
52-Week High0.16
52-Week Low0.05
Moving Average 50 Days0.05
Moving Average 200 Days0.07

Statistics

Average Volume132,474
Shares Outstanding100.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateNovember 22, 2019